Medigen Vaccine Biologics Corp.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.50 TWD
−80.47 M TWD
605.64 M TWD
238.94 M
About Medigen Vaccine Biologics Corp.
Sector
Industry
CEO
Tsan Jian Chen
Website
Headquarters
Zhubei
Founded
2012
Identifiers
2
ISIN:TW0006547003
Medigen Vaccine Biologics Corp. engages in the research, development, and wholesale of vaccine and biopharmaceutical, and wholesale and retail of medical devices. The company was founded on October 12, 2012 and is headquartered in Zhubei, Taiwan.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6547 is 38.30 TWD — it has increased by 2.04% in the past 24 hours. Watch Medigen Vaccine Biologics Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange Medigen Vaccine Biologics Corp. stocks are traded under the ticker 6547.
6547 stock has fallen by −4.52% compared to the previous week, the month change is a 3.62% rise, over the last year Medigen Vaccine Biologics Corp. has showed a 3.10% increase.
6547 reached its all-time high on May 17, 2021 with the price of 280.20 TWD, and its all-time low was 15.15 TWD and was reached on Aug 24, 2015. View more price dynamics on 6547 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6547 stock is 5.22% volatile and has beta coefficient of 0.77. Track Medigen Vaccine Biologics Corp. stock price on the chart and check out the list of the most volatile stocks — is Medigen Vaccine Biologics Corp. there?
Today Medigen Vaccine Biologics Corp. has the market capitalization of 13.18 B, it has decreased by −5.26% over the last week.
Yes, you can track Medigen Vaccine Biologics Corp. financials in yearly and quarterly reports right on TradingView.
Medigen Vaccine Biologics Corp. is going to release the next earnings report on Mar 12, 2026. Keep track of upcoming events with our Earnings Calendar.
6547 net income for the last quarter is −22.60 M TWD, while the quarter before that showed −99.89 M TWD of net income which accounts for 77.38% change. Track more Medigen Vaccine Biologics Corp. financial stats to get the full picture.
No, 6547 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medigen Vaccine Biologics Corp. EBITDA is −27.45 M TWD, and current EBITDA margin is −1.52%. See more stats in Medigen Vaccine Biologics Corp. financial statements.
Like other stocks, 6547 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medigen Vaccine Biologics Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Medigen Vaccine Biologics Corp. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Medigen Vaccine Biologics Corp. stock shows the sell signal. See more of Medigen Vaccine Biologics Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.